e-learning
resources
Vienna 2009
Monday, 14.09.2009
Biological and clinical markers in lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
EGFR – a useful biomarker?
A. Antunes, J. Gomes, C. Lima, P. Brinca, J. C. Machado, B. Parente (Vila Nova Gaia, Porto, Portugal; Stckholm, Sweden)
Source:
Annual Congress 2009 - Biological and clinical markers in lung cancer
Session:
Biological and clinical markers in lung cancer
Session type:
Thematic Poster Session
Number:
2663
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Antunes, J. Gomes, C. Lima, P. Brinca, J. C. Machado, B. Parente (Vila Nova Gaia, Porto, Portugal; Stckholm, Sweden). EGFR – a useful biomarker?. Eur Respir J 2009; 34: Suppl. 53, 2663
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
LungPoint® – A new approach to peripheral lung lesions
Source: Annual Congress 2010 - Tissue is mostly the issue: diagnostic and therapeutic bronchoscopy
Year: 2010
TTF-1 in advanced SCLC – Diagnostic and prognostic relevance
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011
6-minute-walk in lung cancer – a new predictor for response and the performance status?
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009
Airway resistances: R
aw
, sR
aw
, sR
eff
– Which is the best determinant of airway function?
Source: Annual Congress 2010 - Lung function from infancy to adulthood
Year: 2010
Documentation & accuracy of smoking status – An educational need?
Source: Annual Congress 2011 - Smoking cessation science and smoking-related disorders
Year: 2011
Freeflowmetry – The new method of evaluation of the respiratory function phenotype
Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases
Year: 2011
Adrenomedullin – a protective factor in asthma?
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009
Triple 0 – A new respiratory syndrome?
Source: Annual Congress 2012 - Advanced experience with long-term noninvasive ventilation and late-breaking abstracts
Year: 2012
Ways to shorten the lung clearance index measurement ΙΙ – How long to wash?
Source: Annual Congress 2012 - New developments in paediatric respiratory physiology
Year: 2012
Multiple kinds of cancer in one person – Lung and breast cancer – And other malignant entities
Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series
Year: 2010
How should we investigate the child with difficult asthma – Is there any evidence?
Source: Annual Congress 2010 - Quality of life, asthma control and monitoring childhood asthma
Year: 2010
Finding the missing millions with COPD – Does it work?
Source: Annual Congress 2012 - Going with the flow: assessment and evaluation of airway function and its role in patient management
Year: 2012
EGFR and hTERT expression in high risk COPD patients – clinical application
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009
Ways to shorten the lung clearance index measurement I – Are three measurements needed?
Source: Annual Congress 2012 - New understanding of childhood lung disease through physiological measurement
Year: 2012
Evaluation of difficult asthma – a single centre experience
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009
HbA1c in pulmonary arterial hypertension – A marker of prognostic relevance?
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Year: 2012
Pulmonary rehabilitation in patients with interstitial lung disease – An useful therapeutic option?
Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD
Year: 2011
Tuberculosis – An important risk factor for lung cancer
Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities
Year: 2010
T spot TB reactivity – ²to treat or not to treat²
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009
Freeflowmetry – The proposal of the new method of evaluation of the respiratory function phenotype
Source: Annual Congress 2010 - Advances in lung function II
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept